123ArticleOnline Logo
Welcome to 123ArticleOnline.com!
ALL >> Health >> View Article

Odylsa Develops And Manufactures Registered Biocides To Prevention And Control Legionellosis

Profile Picture
By Author: thoma sharris
Total Articles: 1
Comment this article
Facebook ShareTwitter ShareGoogle+ ShareTwitter Share

Legionellosis is a collective name for the clinical syndromes caused by members of the genus, Legionella
Legionellosis is an environmentally acquired bacterial pneumonia with no person-to-person spread. Transmission of the disease may, in susceptible people, follow inhalation of aerosol contaminated with pathogenic Legionellae. Known sources of infective aerosols include evaporative cooling towers, showers, water taps, nebulisers and whirlpool spas.

Legionnaires' disease is the most severe form of legionellosis and it is an important cause of community-acquired pneumonia. European and North American studies have estimated that Legionella species may cause between 2 and 15 per cent of all community-acquired pneumonia requiring hospitalisation. The case fatality rate has been reported as ranging from 5 to 30 per cent, depending on the underlying risk factors of the patients.

Where does it come from?

Outbreaks occur from purpose-built water systems where temperatures are warm enough to encourage growth of the bacteria, e.g. in cooling towers, evaporative condensers and whirlpool spas (tradename Jaccuzi) ...
... and from water used for domestic purposes in buildings such as hotels.


What measures are there to control Legionnaires' disease?

To prevent the Legionnaires' disease, companies that operate these systems must comply with regulations requiring them to manage, maintain and treat them properly. Amongst other things, this means that the water must be treated and the system cleaned regularly.

Our company Odyl focused on developing, manufacturing and implementing effective biocide against Legionella pneumophila, which causes Legionnaires' disease. The control must be continuous through the installations acording to the decrees described in RD 865/2003.

We have a wide offer of biocides registered in the Official Register of Biocides.

ODYL, S.A. Designs programs to control Legionella combining oxidizing biocides, biodispersants, taking into account the costs of operation and characteristics of each installation.

Services for prevention and control of Legionellosis

ODYL, Inc. Can provide you additives to facilitate the disinfection treatment and periodic maintenance of the installation as well as provide a technician to oversee the process and make the necessary analysis for this purpose.

Services:Cleaning and disinfecting, maintenance treatments, chlorination of the water distribution network health, technical and legal advice, technical inspections and audits, advice on the development of self-management plans.

ODYL, S.A. provides resources and expertise for the design, implementation and monitoring of programs for prevention of legionellosis risk facilities that required legislation R.D. 865/2003 of 4 July and regional decrees implementing it.

We implement in your company a complete program for Prevention and Control of Legionellosis consisting of:

Self designed plans: we can provide technical support to the development of the software required for the establishment of self-management plan, using the required methodology. An specialist along with his staff prepares to implement the document and will assist in its implementation.

Program cleaning, disinfection and review of facilities: The cleaning and disinfection program must ensure the mandatory periodic cleaning and disinfection
according to a previously established schedule. We have technical staff to carry out these operations with maximum efficiency and less impact on the environment and facilities.

Biocide treatment with registered products: the control of biological growth in the circuits, including Legionella spp, have registered biocides
various active principles. . The ultimate goal is to keep the circuits within the margins required by legislation and the possible thermal efficiency.

Analytical control: ODYL, S.A. has approved laboratory to perform chemical and microbiological analysis. We also collaborate with external laboratories accredited
for performing determinations of total aerobic Legionella spp or in areas far from our headquarters.

Technical and legal advice: our technicians will advise and accompany you at all times to assist in complying with current legislation.
Our company Odyl focused on developing, manufacturing and implementing effective biocide against
Legionella pneumophila, which causes Legionnaires' disease. The control must be continuous through the installations acording to the decrees described in RD 865/2003.
If you want to know more information,please visit our site:http://www.odylsa.es/index.php?/productos-y-servicios/

Total Views: 46Word Count: 622See All articles From Author

Add Comment

Health Articles

1. Is A Body Sculpting Suit For Slimming Good For Health?
Author: Ayush Pareek

2. Eastern Europe Molecular Diagnostics Market Post-pandemic Outlook
Author: Ajay M

3. Clinical Laboratory Services Market In Europe: Outlook And Future Demand
Author: Ajay M

4. Best Ayurvedic & Allopathic Diabetes Clinics In Hyderabad Compared
Author: immense

5. Best Endocrinologists Vs Diabetologists In Hyderabad – What’s The Difference?
Author: immense

6. Why Regular Hba1c Testing Is Crucial – Insights From Kukatpally Specialists
Author: immense

7. Benefits Of Choosing Sci Ivf Hospital For Surrogacy Treatment In India
Author: Surrogacy Centre India

8. Echocardiography Market Adoption Accelerates In Homecare Settings
Author: Ajay M

9. Living With Tinnitus; How Do You Manage It?
Author: Alicia Reno

10. Electronic Health Records Market Shaping Future Of Patient-centered Care
Author: Ajay M

11. 5 Unusual Heart Attack Symptoms You Shouldn't Ignore
Author: Monica Quinn

12. Massage Boosts Your Immunity Naturally
Author: janani

13. Why Black Truffle Is Canada’s New Favorite Exotic Strain
Author: James Franklin

14. Cancer Therapies For Better Outcomes
Author: Meds

15. Cancer Immunotherapy Market Safety Profiles And Pharmacovigilance
Author: Kane smith

Login To Account
Login Email:
Password:
Forgot Password?
New User?
Sign Up Newsletter
Email Address: